1. Home
  2. XLO vs DHAI Comparison

XLO vs DHAI Comparison

Compare XLO & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • DHAI
  • Stock Information
  • Founded
  • XLO 2016
  • DHAI 2007
  • Country
  • XLO United States
  • DHAI United States
  • Employees
  • XLO N/A
  • DHAI N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • DHAI
  • Sector
  • XLO Health Care
  • DHAI
  • Exchange
  • XLO Nasdaq
  • DHAI NYSE
  • Market Cap
  • XLO 42.2M
  • DHAI 49.1M
  • IPO Year
  • XLO 2021
  • DHAI N/A
  • Fundamental
  • Price
  • XLO $1.07
  • DHAI $0.23
  • Analyst Decision
  • XLO Buy
  • DHAI
  • Analyst Count
  • XLO 1
  • DHAI 0
  • Target Price
  • XLO $4.00
  • DHAI N/A
  • AVG Volume (30 Days)
  • XLO 2.9M
  • DHAI 1.2M
  • Earning Date
  • XLO 05-08-2025
  • DHAI 07-14-2025
  • Dividend Yield
  • XLO N/A
  • DHAI N/A
  • EPS Growth
  • XLO N/A
  • DHAI N/A
  • EPS
  • XLO N/A
  • DHAI N/A
  • Revenue
  • XLO $9,274,000.00
  • DHAI $69,573,000.00
  • Revenue This Year
  • XLO $299.61
  • DHAI N/A
  • Revenue Next Year
  • XLO $1.99
  • DHAI N/A
  • P/E Ratio
  • XLO N/A
  • DHAI N/A
  • Revenue Growth
  • XLO N/A
  • DHAI 5.40
  • 52 Week Low
  • XLO $0.62
  • DHAI $0.12
  • 52 Week High
  • XLO $1.70
  • DHAI $3.67
  • Technical
  • Relative Strength Index (RSI)
  • XLO 64.52
  • DHAI 52.42
  • Support Level
  • XLO $0.86
  • DHAI $0.21
  • Resistance Level
  • XLO $0.92
  • DHAI $0.28
  • Average True Range (ATR)
  • XLO 0.11
  • DHAI 0.03
  • MACD
  • XLO 0.02
  • DHAI 0.01
  • Stochastic Oscillator
  • XLO 77.18
  • DHAI 63.15

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About DHAI DIH HOLDINGS US INC

DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.

Share on Social Networks: